Meds and you

13 December 2010

Pain meds withdrawn from SA market

Healthcare company Adcock Ingram Holdings confirmed it had withdrawn its dextro propoxyphene-containing medicines from the South African market.

Healthcare company Adcock Ingram Holdings confirmed it had withdrawn its dextro propoxyphene (DPP)-containing medicines from the South African market, Fin24 reported. The three products are Synap Forte, Lentogesic and Doxyfene, that are used for pain relief.

Adcock Ingram received notification from the MCC relating to the withdrawal of DPP-containing medicines. The MCC has resolved that all DPP containing medicines be withdrawn from the market,  that  there will be no new prescriptions of DPP allowed; and for patients for whom DPP containing medicines cannot be withdrawn immediately, a 3 month change over period will be permitted during which patients should be switched to an alternative therapy.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.